Senate Drug Pricing Bill Unveiled; House Passes CREATES Act; AMCP Comments on Biosimilar and Interchangeable Insulin Products; AMCP Comments on Proposed Rule on Information Blocking; CMS Issues RFI on Reducing Administrative Burden to 'Put Patients Over Paperwork'; AMCP’s PA and UM Concepts in Managed Care Pharmacy Is Available in JMCP
Recent House Activities; Eye on the States; Nonproprietary Naming of Biological Products; Interchangeability with Reference Product; Drug Price Transparency in Medicare & Medicaid; PA and UM Concepts in Managed Care Pharmacy
Leg-Reg Briefing February 2019: Congress Focuses on Pharmaceutical Pricing; States Introduce Bills Affecting Managed Care Pharmacy; Modifying HIPAA Rules to Improve Coordinated Care
Leg-Reg Briefing January 2019: Congress Starts Amid Ongoing Partial Shutdown; Most States Start 2019 Sessions; AMCP to Increase Grassroots Advocacy Efforts
Leg-Reg Briefing December 2018: Advocacy on Many Fronts; 2019 State Advocacy Coordinators; Proposed Rule on Part D and Medicare Advantage; Regulations on Drug Pricing Transparency